CSRXP APPLAUDS SENATE PASSAGE OF USMCA THAT PUTS AMERICAN PATIENTS FIRST

01-16-2020 Press Release

Lawmakers Hold Strong, Advance Trade Deal Without Big Pharma-Backed Provision on Biologic Exclusivity For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) applauded U.S. Senators Thursday who voted to approve the revised U.S.-Mexico-Canada Agreement (USMCA) without a provision that would have helped brand name drug companies […]

CSRXP APPLAUDS INCLUSION OF CREATES IN SPENDING DEAL; URGES CONGRESS TO KEEP WORKING TO HOLD BIG PHARMA ACCOUNTABLE, LOWER Rx PRICES

12-16-2019 Press Release

Passage of Bipartisan, Market-based CREATES Act Will Be A First Step in the Right Direction But Patients Need Washington to Do Much More  For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) commended Congress for including the bipartisan, market-based Creating and Restoring Equal Access To Equivalent […]

CSRXP: THE HOUSE HAS ACTED, TIME FOR SENATE TO DO ITS JOB

12-12-2019 Press Release

Passage of HR3 Adds to Momentum to Hold Big Pharma Accountable; Now Congress Must Move Swiftly to Get Bipartisan Reforms Passed into Law For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) commended lawmakers in the U.S. House for passing market-based reforms included in the Elijah E. […]

CSRXP APPLAUDS USMCA CHANGES TO PUT AMERICAN PATIENTS FIRST

12-10-2019 Press Release

Revisions to Historic Trade Deal Remove Big Pharma Carveout For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) commended the White House and lawmakers in the U.S. House for removing provisions from the U.S.-Mexico-Canada Agreement (USMCA) that were supported by Big Pharma and that would have […]

CSRXP ANALYSIS: BIG PHARMA SPENT TAX WINDFALL ON PROFITS, NOT R&D

12-10-2019 Press Release

Corporate Filings Show Drug Makers Boosted Payouts for Shareholders 17 Times More Than Increased Investment in ‘Innovation’ For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released an analysis Tuesday that found brand name prescription drug manufacturers used a windfall from the Tax Cuts and Jobs […]

CSRXP SENATE BATTLEGROUND POLL: VOTERS BACK GRASSLEY-WYDEN, DEMAND ACTION TO HOLD BIG PHARMA ACCOUNTABLE

11-22-2019 Press Release

Survey Finds Overwhelming Majorities of Swing State Voters Blame Drug Makers for Rising Prices and Want Congress to Pass Bipartisan Reforms Before Year End For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Friday on a new survey conducted in five top 2020 […]

CSRxP: Policymakers Must Remove Big Pharma Carveout in USMCA

10-23-2019 Press Release

Washington Can Put Patients First By Amending Trade Provision That Would Hamper Generic and Biosimilar Competition For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) reiterated Wednesday the urgent need for the administration and Congress to amend the proposed U.S.-Mexico-Canada Agreement (USMCA) to remove provisions that […]

CSRXP URGES HOUSE LAWMAKERS TO CONTINUE WORKING ACROSS PARTY LINES TO HOLD BIG PHARMA ACCOUNTABLE

10-16-2019 Press Release

Trio of Committee Proceedings on Drug Pricing Offer Chance to Focus on Areas of Bipartisan Consensus For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Wednesday ahead of three legislative proceedings on drug pricing proposals scheduled for Thursday. The U.S. House Committee on […]

CSRxP Urges E&C Lawmakers to Continue Building Bipartisan Consensus

09-23-2019 Press Release

Hearing on Drug Pricing Proposals an Opportunity for Focus on Areas of Agreement to Hold Big Pharma Accountable and Lower Drug Prices  For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Monday ahead of a U.S. House Committee on Energy and Commerce Subcommittee on […]

CSRxP: House Rx Package Adds to Unprecedented Momentum to Hold Big Pharma Accountable

09-19-2019 Press Release

Speaker’s Drug Pricing Plan Includes Measures That Have Won Support from Both Sides of the Aisle For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today on the release of details of a drug pricing plan circulated by U.S. House Speaker Nancy Pelosi […]

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.